177 related articles for article (PubMed ID: 38765596)
21. Effectiveness and safety of vitamin D in relation to bone health.
Cranney A; Horsley T; O'Donnell S; Weiler H; Puil L; Ooi D; Atkinson S; Ward L; Moher D; Hanley D; Fang M; Yazdi F; Garritty C; Sampson M; Barrowman N; Tsertsvadze A; Mamaladze V
Evid Rep Technol Assess (Full Rep); 2007 Aug; (158):1-235. PubMed ID: 18088161
[TBL] [Abstract][Full Text] [Related]
22. Serum sclerostin is associated with recurrent kidney stone formation independent of hypercalciuria.
Rodríguez D; Gurevich E; Mohammadi Jouabadi S; Pastor Arroyo EM; Ritter A; Estoppey Younes S; Wagner CA; Imenez Silva PH; Seeger H; Mohebbi N
Clin Kidney J; 2024 Jan; 17(1):sfad256. PubMed ID: 38186870
[TBL] [Abstract][Full Text] [Related]
23. Distinct phenotype of kidney stone formers with renal phosphate leak.
Dhayat NA; Lüthi D; Schneider L; Mattmann C; Vogt B; Fuster DG
Nephrol Dial Transplant; 2019 Jan; 34(1):129-137. PubMed ID: 29939320
[TBL] [Abstract][Full Text] [Related]
24. Idiopathic calcium nephrolithiasis with pure calcium oxalate composition: clinical correlates of the calcium oxalate dihydrate/monohydrate (COD/COM) stone ratio.
Guerra A; Ticinesi A; Allegri F; Pinelli S; Aloe R; Meschi T
Urolithiasis; 2020 Jun; 48(3):271-279. PubMed ID: 31506762
[TBL] [Abstract][Full Text] [Related]
25. AN INFANT WITH IDIOPATHIC HYPERCALCIURIA AND NEPHROLITHIASIS ASSOCIATED WITH CYP24A1 ENZYME POLYMORPHISM: A CASE REPORT.
Trutin I; Škorić I
Acta Clin Croat; 2022 Feb; 60(3):544-547. PubMed ID: 35282483
[TBL] [Abstract][Full Text] [Related]
26. Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.
Tebben PJ; Singh RJ; Kumar R
Endocr Rev; 2016 Oct; 37(5):521-547. PubMed ID: 27588937
[TBL] [Abstract][Full Text] [Related]
27. Role of 1,25-dihydroxy vitamin D3 and parathyroid hormone in urinary calcium excretion in calcium stone formers.
Kim WT; Kim YJ; Yun SJ; Shin KS; Choi YD; Lee SC; Kim WJ
Yonsei Med J; 2014 Sep; 55(5):1326-32. PubMed ID: 25048492
[TBL] [Abstract][Full Text] [Related]
28. Vascular calcification and bone mineral density in recurrent kidney stone formers.
Shavit L; Girfoglio D; Vijay V; Goldsmith D; Ferraro PM; Moochhala SH; Unwin R
Clin J Am Soc Nephrol; 2015 Feb; 10(2):278-85. PubMed ID: 25635036
[TBL] [Abstract][Full Text] [Related]
29. Differential diagnosis of vitamin D-related hypercalcemia using serum vitamin D metabolite profiling.
Kaufmann M; Schlingmann KP; Berezin L; Molin A; Sheftel J; Vig M; Gallagher JC; Nagata A; Masoud SS; Sakamoto R; Nagasawa K; Uesugi M; Kottler ML; Konrad M; Jones G
J Bone Miner Res; 2021 Jul; 36(7):1340-1350. PubMed ID: 33856702
[TBL] [Abstract][Full Text] [Related]
30. A pilot study of the effect of sodium thiosulfate on urinary lithogenicity and associated metabolic acid load in non-stone formers and stone formers with hypercalciuria.
Okonkwo OW; Batwara R; Granja I; Asplin JR; Goldfarb DS
PLoS One; 2013; 8(4):e60380. PubMed ID: 23593205
[TBL] [Abstract][Full Text] [Related]
31. Vitamin D status in patients with recurrent kidney stones.
Pipili C; Oreopoulos DG
Nephron Clin Pract; 2012; 122(3-4):134-8. PubMed ID: 23712072
[TBL] [Abstract][Full Text] [Related]
32. The relationship of 3' vitamin D receptor haplotypes to urinary supersaturation of calcium oxalate salts and to age at onset and familial prevalence of nephrolithiasis.
Mossetti G; Rendina D; Viceconti R; Manno G; Guadagno V; Strazzullo P; Nunziata V
Nephrol Dial Transplant; 2004 Sep; 19(9):2259-65. PubMed ID: 15213319
[TBL] [Abstract][Full Text] [Related]
33. 3' Untranslated Region Structural Elements in CYP24A1 Are Associated With Infantile Hypercalcemia Type 1.
Ball N; Duncan S; Zhang Y; Payet R; Piec I; Whittle E; Tang JCY; Schoenmakers I; Lopez B; Chipchase A; Kumar A; Perry L; Maxwell H; Ding Y; Fraser WD; Green D
J Bone Miner Res; 2023 Mar; 38(3):414-426. PubMed ID: 36625425
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for nephrolithiasis in patients with familial idiopathic hypercalciuria.
Lerolle N; Lantz B; Paillard F; Gattegno B; Flahault A; Ronco P; Houillier P; Rondeau E
Am J Med; 2002 Aug; 113(2):99-103. PubMed ID: 12133747
[TBL] [Abstract][Full Text] [Related]
35. Association between Circulating Vitamin D Level and Urolithiasis: A Systematic Review and Meta-Analysis.
Hu H; Zhang J; Lu Y; Zhang Z; Qin B; Gao H; Wang Y; Zhu J; Wang Q; Zhu Y; Xun Y; Wang S
Nutrients; 2017 Mar; 9(3):. PubMed ID: 28335477
[TBL] [Abstract][Full Text] [Related]
36. Clinical and Metabolic Correlates of Calcium Oxalate Stone Subtypes: Implications for Etiology and Management.
Bamberger JN; Blum KA; Kan KM; Parkhomenko E; Gallante B; Gupta M
J Endourol; 2019 Sep; 33(9):755-760. PubMed ID: 31154910
[No Abstract] [Full Text] [Related]
37. Juvenile onset IIH and
Schlingmann KP; Cassar W; Konrad M
Bone Rep; 2018 Dec; 9():42-46. PubMed ID: 30591926
[TBL] [Abstract][Full Text] [Related]
38. PTH and 1.25 vitamin D response to a low-calcium diet is associated with bone mineral density in renal stone formers.
Pasch A; Frey FJ; Eisenberger U; Mohaupt MG; Bonny O
Nephrol Dial Transplant; 2008 Aug; 23(8):2563-70. PubMed ID: 18398019
[TBL] [Abstract][Full Text] [Related]
39. Association of hypercalciuria with vitamin D supplementation in patients undergoing ketogenic dietary therapy.
Lee M; Lee HI; Song K; Choi HS; Suh J; Kim SH; Chae HW; Kang HC; Lee JS; Kim HD; Kim HS; Kwon A
Front Nutr; 2022; 9():970467. PubMed ID: 36118750
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
